Edwards Comprehensive Cancer Center

What Edwards Comprehensive Cancer Center does

Edwards Comprehensive Cancer Center (ECCC) is a nonprofit, hospital-affiliated comprehensive cancer center located in a 70,000 square-foot facility at 1400 Hal Greer Boulevard in Huntington, West Virginia. It operates within Marshall Health Network and is jointly directed by Cabell Huntington Hospital and the Joan C. Edwards School of Medicine at Marshall University. ECCC houses the James F. Edwards Adult Cancer Clinic and the Joan C. Edwards Children's Cancer Clinic, delivering multidisciplinary oncology care across medical, radiation, and surgical oncology; breast, lung, colorectal, gynecologic, urologic, orthopedic, neuro, and pediatric oncology; and supportive care services such as survivorship, nutrition, social work, and palliative medicine. Its patient base spans 29+ counties across West Virginia, eastern Kentucky, and southern Ohio, making it the only comprehensive academic cancer center in the Tri-State region.

The center's technology stack includes the da Vinci Xi Surgical System (with approximately 20 trained surgeons across OB/GYN, urology, urologic oncology, and general surgery), the Monarch AI-enhanced robotic bronchoscopy platform for lung cancer diagnosis, the TrueBeam linear accelerator, 3D mammography (digital breast tomosynthesis), Varian 21Ex linear accelerator, Varian Eclipse treatment planning, GE CT/SIM scanner, High Dose Rate Brachytherapy, respiratory gating, and an OpenSpecimen-managed Biorepository supporting the Tissue Procurement Program. Advanced modalities are integrated into a multidisciplinary clinic model in which lung and colorectal cancer patients are seen by medical, surgical, and radiation oncologists in a single visit with a shared electronic medical record. The center holds NAPBC breast center accreditation (the only one in the region), ACR Breast Imaging Center of Excellence, ACR Radiation Oncology accreditation, and COEMIG designation (the only West Virginia hospital so recognized), and participates in NCI cooperative group trials (NRG Oncology, Alliance, SWOG, ECOG-ACRIN) alongside investigator-initiated studies through the Marshall University Translational Genomic Research Institute.

ECCC generates revenue primarily through clinical and medical services billed to Medicare, Medicaid, and private insurance, supplemented by clinical trial sponsorship income and philanthropic donations managed by the Cabell Huntington Hospital Foundation (including the Good Samaritan Fund). The go-to-market model is physician referral-driven for adult and pediatric patients via dedicated referral lines, with self-referral pathways for the Hereditary Cancer Risk Assessment Program (free initial consultation) and the Lung Cancer Screening Clinic. Marketing relies on patient and physician spotlights, community support groups such as Sisters of Hope, cancer education content, annual reports, and earned media rather than paid acquisition.

Name

Edwards Comprehensive Cancer Center

Legal name

Edwards Comprehensive Cancer Center

Website

https://edwardsccc.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

Edwards Comprehensive Cancer Center is a nonprofit, hospital-affiliated comprehensive academic cancer center in Huntington, West Virginia, jointly directed by Cabell Huntington Hospital and Marshall University. It delivers multidisciplinary oncology care across adult and pediatric cancers to patients across 29+ counties in West Virginia, eastern Kentucky, and southern Ohio.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Hospitals (8060)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK), Lung Cancer Screening & Pulmonary Nodule Clinic (HLAKANAI), Surgical Oncology (HLAKAFAG)

Keywords

• Comprehensive cancer care
• Oncology treatment services
• Radiation oncology
• Pediatric hematology oncology
• Cancer clinical trials

Headquarters

HQ city

Huntington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Clinical and Medical Services Revenue: As a comprehensive cancer center within a hospital system, the primary revenue is generated from billing for medical services including chemotherapy, radiation therapy, surgery, diagnostic imaging, laboratory testing, and clinical consultations. Services are billed to patients' insurance providers including Medicare, Medicaid, and private insurance.
2. Clinical Trials Program Revenue: The center hosts clinical trials sponsored by the National Cancer Institute, NRG Oncology, Alliance for Clinical Trials, SWOG, ECOG-ACRIN, and industry sponsors. While clinical trial participation is offered to patients, the program generates revenue through trial sponsorships and research grants.
3. Donations and Philanthropy: The center accepts charitable donations managed by the Cabell Huntington Hospital Foundation. Donors may designate gifts to specific services or populations, or contribute to the general fund. The Good Samaritan Fund helps individual cancer patients with specific needs such as wigs, prosthetics, and transportation to treatment.
4. Surgical Services: Revenue from surgical procedures including da Vinci robotic surgeries, with potential for additional revenue from prosthetic and implant materials used in reconstructive procedures.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Edwards Comprehensive Cancer Center is a comprehensive academic cancer center operating within a 70,000 square-foot facility in Huntington, West Virginia, providing diagnosis, treatment, and survivorship services for adult and pediatric cancer patients. The center delivers multidisciplinary cancer care across medical oncology, radiation oncology, surgical oncology, breast oncology, gynecologic oncology, urologic oncology, neuro-oncology, orthopedic oncology, and pediatric oncology, supported by clinical trials, a biorepository, hereditary cancer risk assessment, and patient support services.

Product overview

Edwards Comprehensive Cancer Center is a comprehensive cancer care facility offering a full spectrum of oncology services through multiple specialized programs. The center operates the James F. Edwards Adult Cancer Clinic and Joan C. Edwards Children's Cancer Clinic within a 70,000 square-foot facility. Core clinical programs include Medical Oncology, Radiation Oncology, Surgical Oncology, Diagnostic Breast Center, Gynecologic Oncology, Pediatric Oncology, Urologic Oncology, Neuro-Oncology, Orthopedic Oncology, Lung Cancer Program, and Colorectal Cancer Program. Advanced treatment technologies include the da Vinci Surgical System for robotic surgery, Monarch AI-enhanced robotic bronchoscopy for lung cancer diagnosis, TrueBeam linear accelerator for radiation therapy, and 3D mammography. Research capabilities include Clinical Trials, Tissue Procurement Program, and Biorepository. Support services encompass Cancer Survivorship Program, Oncology Social Work, Nutrition Services, and Supportive Care Medicine. Prevention programs include Hereditary Cancer Risk Assessment, Comprehensive Lung Nodule Program, and Low-Dose CT Screening.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology Program
• Radiation Oncology
• Surgical Oncology
• Diagnostic Breast Center
• Gynecologic Oncology Program
• Pediatric Oncology
• Urologic Oncology Program
• Neuro-Oncology
• Orthopedic Oncology
• Lung Cancer Program
• Colorectal Cancer Program
• Supportive Care Medicine
• Clinical Trials Program
• Hereditary Cancer Risk Assessment Program
• Low-Dose CT Lung Cancer Screening

Quantifiable outcome

• 20% reduction in lung cancer deaths with low-dose CT screening compared to chest X-rays
• +2 more outcomes

Named customers4 records

Segments9 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature8 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• St. Jude Children's Research HospitalcoreStrategic or Co-development PartnerDr. Joshua Hess completed his clinical fellowship in pediatric hematology and oncology at St. Jude Children's Research Hospital from 2017 to 2020. He maintains professional relationships with former colleagues and mentors at St. Jude, enabling consultation and referral connections for patients whose situations require more resources than available locally. This relationship provides ECCC pediatric patients access to world-class pediatric oncology expertise for complex cases.
• Memorial Sloan Kettering Cancer Center (MSKCC)minorStrategic or Co-development PartnerDr. Paul Adedoyin received training from one of the leading experts in spine SRS and stereotactic body radiation therapy at MSKCC during his residency. This training enhanced his expertise in radioisotope treatment for metastatic prostate cancer and prostate brachytherapy.
• National Cancer Institute (NCI)coreStrategic or Co-development PartnerThe center participates in NCI-sponsored research programs and clinical trials including ALCHEMIST, ComboMATCH, Lung-MAP, and other NCI Clinical Trials Network programs. The center also houses the Marshall University Translational Genomic Research Institute which conducts investigator-initiated trials designed by MU researchers and ECCC physicians.
• NRG Oncology, Alliance for Clinical Trials, SWOG, ECOG-ACRINcoreStrategic or Co-development PartnerThe center participates in multiple National Cancer Institute-sponsored clinical research groups including NRG Oncology, Alliance for Clinical Trials in Oncology, SWOG, and ECOG-ACRIN, providing patients access to a broad portfolio of clinical trials across cancer types.
• Children's Hospital AssociationminorStrategic or Co-development PartnerThe Hoops Family Children's Hospital, which houses the pediatric oncology unit, is a member of the Children's Hospital Association, providing access to national resources and best practices for children's hospital care.
• Intuitive SurgicalcoreTechnology or IntegrationIntuitive Surgical is the manufacturer of the da Vinci Surgical System. ECCC and Cabell Huntington Hospital have acquired and deployed da Vinci surgical technology, with approximately 20 surgeons trained on the system. The hospital has three da Vinci systems total (one from 2006, two Xi systems acquired in 2015).
• Cabell Huntington Hospital FoundationcoreGTM or Marketing PartnerThe Cabell Huntington Hospital Foundation manages all donations to the Edwards Comprehensive Cancer Center, including the Good Samaritan Fund which helps individual cancer patients with specific needs such as wigs, prosthetics, and cab fare to treatment. The foundation provides financial stewardship and donor engagement services.
• Harvard Medical SchoolminorStrategic or Co-development PartnerDr. Felix Cheung, the region's only orthopedic surgeon fellowship-trained in musculoskeletal oncology, completed his fellowship at Harvard Medical School, bringing advanced orthopedic oncology training to the ECCC region.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• UK Markey Cancer Center: NCI-designated academic cancer center at the University of Kentucky in Lexington. Comparable comprehensive oncology scope and a direct competitor for eastern Kentucky referrals currently captured by ECCC.
• UPMC Hillman Cancer Center: NCI-designated academic comprehensive cancer center in Pittsburgh serving a tri-state Appalachian region with multidisciplinary clinics, NCI clinical trials, and robotic surgery. Directly comparable in scope, model, and adjacent geography, and a leading out-of-region competitor for complex cases.
• CAMC Cancer Center: Charleston Area Medical Center's cancer program in Charleston, WV, the largest oncology program in West Virginia outside ECCC's catchment. Comparable in offering multidisciplinary cancer care for a similar regional population.
• WVU Cancer Institute: West Virginia's flagship academic cancer center in Morgantown with multidisciplinary oncology, clinical trials, and biomedical research. The closest in-state peer and a competing academic tertiary referral center for ECCC's catchment.

Broad incumbents

• Cleveland Clinic Cancer Center: NCI-designated National Cancer Institute-designated cancer center within Cleveland Clinic, a national brand. Pulls complex cases from southern Ohio and is a higher-tier out-of-region alternative for ECCC patients.
• Vanderbilt-Ingram Cancer Center: NCI-designated Comprehensive Cancer Center and academic institution in Nashville with research-driven multidisciplinary oncology. Comparable in academic cancer center positioning, though geographically distant and operationally larger.
• Ohio State University Comprehensive Cancer Center - James Cancer Hospital: NCI-designated NCI Comprehensive Cancer Center in Columbus, Ohio, adjacent to ECCC's southern Ohio catchment. A larger academic incumbent drawing complex cases from ECCC's region for specialty oncology.

Others

• St. Mary's Medical Center: Hospital in Huntington, WV, part of the same Marshall Health Network footprint as ECCC. Sister facility sharing services and patient flow; an ecosystem peer rather than direct oncology competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/EdwardsCCC
• Facebookfacebook.com/EdwardsComprehensiveCancerCenter
• LinkedInlinkedin.com/company/edwards-comprehensive-cancer-center

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Edwards Comprehensive Cancer Center